Evonik Evonik

X

Find Istaroxime manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Istaroxime
Also known as: 203737-93-3, Istaroxime, (e)-, Pst-2744, W40687go3s, (3e,5s,8r,9s,10r,13s,14s)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione, 203738-46-9
Molecular Formula
C21H32N2O3
Molecular Weight
360.5  g/mol
InChI Key
MPYLDWFDPHRTEG-PAAYLBSLSA-N
FDA UNII
W40687GO3S

1 2D Structure

Istaroxime

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(3E,5S,8R,9S,10R,13S,14S)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione
2.1.2 InChI
InChI=1S/C21H32N2O3/c1-20-7-5-13(23-26-10-9-22)11-17(20)18(24)12-14-15-3-4-19(25)21(15,2)8-6-16(14)20/h14-17H,3-12,22H2,1-2H3/b23-13+/t14-,15-,16-,17+,20+,21-/m0/s1
2.1.3 InChI Key
MPYLDWFDPHRTEG-PAAYLBSLSA-N
2.1.4 Canonical SMILES
CC12CCC(=NOCCN)CC1C(=O)CC3C2CCC4(C3CCC4=O)C
2.1.5 Isomeric SMILES
C[C@]12CC/C(=N\OCCN)/C[C@@H]1C(=O)C[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C
2.2 Other Identifiers
2.2.1 UNII
W40687GO3S
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-((2-aminoethoxy)imino)androstane-6,17-dione

2. 3-((2-aminoethoxy)imino)androstane-6,17-dione Hydrochloride

3. Pst 2744

4. Pst-2744

5. Pst2744

2.3.2 Depositor-Supplied Synonyms

1. 203737-93-3

2. Istaroxime, (e)-

3. Pst-2744

4. W40687go3s

5. (3e,5s,8r,9s,10r,13s,14s)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione

6. 203738-46-9

7. 3-((2-aminoethoxy)imino)-5alpha-androstan-6,17-dione

8. Debio-0614

9. Istaroxime [inn]

10. Unii-w8i9h2tppl

11. Pst 2744

12. St-2744

13. W8i9h2tppl

14. Unii-w40687go3s

15. Chembl469045

16. Schembl7285904

17. Dtxsid20870222

18. Akos024259258

19. Cs-1531

20. Db06157

21. Ac-36855

22. As-78198

23. Hy-15718

24. 5-alpha-androstan-6,17-dione, 3-((2-aminoethoxy)imino)-

25. Androstane-3,6,17-trione, 3-(o-(2-aminoethyl)oxime), (3e,5alpha)-

26. Androstane-3,6,17-trione, 3-(o-(2-aminoethyl)oxime), (3e,5.alpha.)-

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 360.5 g/mol
Molecular Formula C21H32N2O3
XLogP31.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count3
Exact Mass360.24129289 g/mol
Monoisotopic Mass360.24129289 g/mol
Topological Polar Surface Area81.8 Ų
Heavy Atom Count26
Formal Charge0
Complexity645
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in heart disease.


5 Pharmacology and Biochemistry
5.1 Mechanism of Action

Reduces the sodium-potassium adenosine triphosphatase (ATPase) activity and stimulates the sarcoplasmic calcium ATPase isoform 2 reuptake function.


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY